INSYS (INSY) 'Overreacting' to Linden Care News - RBC Capital
RBC Capital analyst Randall Stanicky said shares of INSYS Therapeutics (NASDAQ: INSY) are over reacting to today's Linden Care news.Stanicky ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)